H&R GmbH & Co. KGaA announces its preliminary results for the fiscal year 2023

H&R GmbH & Co. KGaA, a company specializing in chemicals and pharmaceuticals, has released its preliminary results for the fiscal year 2023. Despite a decrease in annual revenue to 1,352.3 million euros from 1,576.0 million euros in 2022, the company achieved an EBITDA of 92.7 million euros, surpassing the latest forecasts. This performance was achieved in a mixed economic environment characterized by favorable raw material supply conditions, acceptable costs for energy and gas thanks to political measures, but also by increased competitive pressure and uncertainty due to military conflicts.

The last quarter of 2023 saw an improvement in EBITDA to 26.1 million euros. However, by the end of the year, the consolidated net profit attributable to shareholders amounted to 10.6 million euros, down from 42.7 million euros in 2022. The company also reported a strong recovery in operating cash flow, reaching 119.1 million euros compared to 38.0 million euros in 2022, which contributed to improving free cash flow. The company expects to publish a comprehensive annual results report and financial annual report on March 28, 2024.